Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma

JAMA. 2023 Jan 17;329(3):260. doi: 10.1001/jama.2022.21030.

Authors

Ya-Ting Hu¹, Yung-Shuo Kao²

Affiliations

¹ School of Post-baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan.
² Dr Kao Clinic, Taichung, Taiwan.

PMID: 36648474
DOI: 10.1001/jama.2022.21030

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Chemoradiotherapy
Disease-Free Survival
Humans
Nasopharyngeal Carcinoma* / drug therapy
Nasopharyngeal Carcinoma* / radiotherapy
Nasopharyngeal Neoplasms* / drug therapy
Nasopharyngeal Neoplasms* / radiotherapy
Neoplasm Staging
Radiotherapy, Intensity-Modulated*
Retrospective Studies